Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Title Grant Type Focus Area Country Application Due Date Treatment Optimization in ALK-positive Metastatic Non-Small Cell Lung CancerRelease Date:Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Iceland, Italy, Netherlands, Norway, Portugal, Spain, Swaziland, Sweden, USA, United Kingdom Immunotherapy in High-risk Non-Muscle Invasive Bladder CancerRelease Date:Education Oncology USA Advances in Migraine TreatmentRelease Date:Education Internal Medicine All 2022/2023 Global Obesity ASPIRERelease Date:Research Internal Medicine All Evolving Concepts in Biosimilar Optimization in Inflammatory DiseasesRelease Date:Education Inflammation & Immunology USA Underlying medical conditions and other risk factors, higher risk of severe COVID-19 (European)Release Date:Education Hospital All Building Capacity to Address Health Disparities in the US through AMS Telehealth and Tele-mentoringRelease Date:Quality Improvement Hospital USA 2022/2023 Global NASH ASPIRERelease Date:Research Internal Medicine All 2023 Growth Hormone ResearchRelease Date:Research Rare Disease All Antimicrobial Resistance Testing and Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital All Medication Error Reduction Strategies in the Hospital SettingRelease Date:Education Hospital USA 2022/2023 Global Cachexia ASPIRERelease Date:Research Internal Medicine All